INTERFERON BETA-1B for Primary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where INTERFERON BETA-1B was used for Primary progressive multiple sclerosis.
Most Reported Side Effects for INTERFERON BETA-1B
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 1,229 | 10.0% | 12 | 312 |
| Influenza like illness | 1,042 | 8.4% | 1 | 110 |
| Injection site pain | 1,014 | 8.2% | 3 | 122 |
| Fatigue | 783 | 6.3% | 9 | 130 |
| Drug ineffective | 767 | 6.2% | 7 | 53 |
| Injection site erythema | 724 | 5.9% | 1 | 73 |
| Injection site reaction | 707 | 5.7% | 0 | 86 |
| Pain | 597 | 4.8% | 6 | 115 |
| Headache | 596 | 4.8% | 6 | 134 |
| Multiple sclerosis | 589 | 4.8% | 24 | 116 |
| Gait disturbance | 525 | 4.3% | 7 | 157 |
| Death | 501 | 4.1% | 501 | 41 |
| Injection site bruising | 480 | 3.9% | 0 | 32 |
| Pyrexia | 475 | 3.9% | 10 | 135 |
| Chills | 460 | 3.7% | 3 | 69 |
Other Indications for INTERFERON BETA-1B
Multiple sclerosis (7,192)
Product used for unknown indication (842)
Relapsing-remitting multiple sclerosis (694)
Secondary progressive multiple sclerosis (146)
Covid-19 (93)
Multiple sclerosis relapse (28)
Chronic myeloid leukaemia (26)
Clinically isolated syndrome (18)
Covid-19 pneumonia (16)
Relapsing multiple sclerosis (15)
Other Drugs Used for Primary progressive multiple sclerosis
OCRELIZUMAB (6,156)
RITUXIMAB (147)
DALFAMPRIDINE (71)
FINGOLIMOD (66)
SIPONIMOD (60)
UNSPECIFIED INGREDIENT (34)
OFATUMUMAB (32)
GLATIRAMER (30)
INTERFERON BETA-1A (27)
NATALIZUMAB (27)